Paper42010540
Genomic landscape of cholangiocarcinoma in India: ethnic variants and implications for targeted therapy.
Suryavanshi M and 11 others. BMC Cancer, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Genomic landscape of cholangiocarcinoma in India: ethnic variants and implications for targeted therapy. Papers, record 42010540. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42010540
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Genomic landscape of cholangiocarcinoma in India: ethnic variants and implications for targeted therapy.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cholangiocarcinoma | Major topic |
| Bile Duct Neoplasms | Major topic |
| Biomarkers, Tumor | Major topic |
| Humans | |
| India | |
| Male | |
| Female | |
| Middle Aged | |
| Retrospective Studies | |
| Mutation | |
| Aged | |
| Genomics | |
| High-Throughput Nucleotide Sequencing | |
| Adult | |
| Isocitrate Dehydrogenase | |
| Molecular Targeted Therapy | |
| Class I Phosphatidylinositol 3-Kinases | |
| Tumor Suppressor Protein p53 | |
| Proto-Oncogene Proteins p21(ras) | |
| Ubiquitin Thiolesterase | |
| Tumor Suppressor Proteins |
Source PubMed
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24185513 | Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers. | Nat Genet | 2013 | https://conductscience.org/library/papers/24185513 | PubMed |
| 2 | 25526346 | Mutational landscape of intrahepatic cholangiocarcinoma. | Nat Commun | 2014 | https://conductscience.org/library/papers/25526346 | PubMed |
| 3 | 25693006 | Genetics of Opisthorchis viverrini-related cholangiocarcinoma. | Curr Opin Gastroenterol | 2015 | https://conductscience.org/library/papers/25693006 | PubMed |
| 4 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 5 | 25608663 | Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma. | Nat Commun | 2015 | https://conductscience.org/library/papers/25608663 | PubMed |
| 6 | 30178032 | Nab-Paclitaxel and Gemcitabine as First-line Treatment of Advanced or Metastatic Cholangiocarcinoma: A Phase 2 Clinical Trial. | JAMA Oncol | 2018 | https://conductscience.org/library/papers/30178032 | PubMed |
| 7 | 29848569 | Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention. | Clin Cancer Res | 2018 | https://conductscience.org/library/papers/29848569 | PubMed |
| 8 | 32923885 | Intrahepatic Cholangiocarcinoma: Genomic Heterogeneity Between Eastern and Western Patients. | JCO Precis Oncol | 2020 | https://conductscience.org/library/papers/32923885 | PubMed |
| 9 | 31130341 | Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes. | Cancer Cell | 2019 | https://conductscience.org/library/papers/31130341 | PubMed |
| 10 | 24185509 | Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas. | Nat Genet | 2013 | https://conductscience.org/library/papers/24185509 | PubMed |
| 11 | 22561520 | Exome sequencing of liver fluke-associated cholangiocarcinoma. | Nat Genet | 2012 | https://conductscience.org/library/papers/22561520 | PubMed |
| 12 | 34868996 | Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology. | Front Oncol | 2021 | https://conductscience.org/library/papers/34868996 | PubMed |
| 13 | 33963001 | Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection. | Clin Cancer Res | 2021 | https://conductscience.org/library/papers/33963001 | PubMed |
| 14 | 41520156 | Actionable genomic landscape of biliary tract cancer in the Indian population. | Oncologist | 2026 | https://conductscience.org/library/papers/41520156 | PubMed |
| 15 | 32620281 | Cholangiocarcinoma: Diagnosis and Management. | Clin Liver Dis | 2020 | https://conductscience.org/library/papers/32620281 | PubMed |
| 16 | 36935431 | Targeted molecular profiling of solid tumours-Indian tertiary cancer centre experience. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/36935431 | PubMed |
| 17 | 36033540 | Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials. | Front Oncol | 2022 | https://conductscience.org/library/papers/36033540 | PubMed |
| 18 | 28667006 | Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma. | Cancer Discov | 2017 | https://conductscience.org/library/papers/28667006 | PubMed |
| 19 | 37709624 | Epidemiology of cholangiocarcinoma. | Eur J Surg Oncol | 2025 | https://conductscience.org/library/papers/37709624 | PubMed |
| 20 | 36999984 | p53 protects against formation of extrahepatic biliary precancerous lesions in the context of oncogenic Kras. | Oncotarget | 2023 | https://conductscience.org/library/papers/36999984 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42010540
GET https://conductscience.org/api/papers/v1/42010540/references?page=2